Geulah Livshits Analyst PerformanceSenior Research Analyst, Biotech at Chardan CapitalGeulah Livshits is a stock analyst at Chardan Capital, covering 31 publicly traded companies across a range of sectors. Over the past year, Geulah Livshits has issued 63 stock ratings, including buy and hold recommendations. While full access to Geulah Livshits' proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Geulah Livshits' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings168 Last 6 YearsBuy Recommendations97.62% 164 Buy RatingsCompanies Covered31 Unique Companies Ratings Distribution168RatingsDistribution of strong buy, buy, hold, and sell ratings by Geulah Livshits.RatingPercentageCount Strong Buy0.0%0 ratings Buy97.6%164 ratings Hold2.4%4 ratings Sell0.0%0 ratingsOut of 168 total stock ratings issued by Geulah Livshits at Chardan Capital, the majority (97.6%) have been Buy recommendations, followed by 2.4% Hold.Best & Worst CallsBest Call0000.0%MRNAFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%VINCDec 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ93.5% of companies on NASDAQ29 companiesNYSE6.5% of companies on NYSE2 companiesGeulah Livshits, an analyst at Chardan Capital, currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical30 companies96.8%Retail/Wholesale1 company3.2%Geulah Livshits of Chardan Capital specializes in stock coverage within the Medical sector, with additional focus on Retail/Wholesale companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE19 companies61.3%MED - DRUGS4 companies12.9%PHARMACEUTICAL PREPARATIONS4 companies12.9%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC2 companies6.5%MED - GENERIC DRG1 company3.2%CATALOG & MAIL - ORDER HOUSES1 company3.2% About Geulah LivshitsDr. Geulah Livshits is a Senior Research Analyst at Chardan covering biotech companies, with a focus on gene editing and oncology. Dr. Geulah Livshits joined Chardan in the spring of 2018, after a career as an academic scientist. Prior to joining Chardan, Dr. Livshits was a Postdoctoral Research Fellow in the laboratory of Dr. Scott Lowe at Memorial Sloan Kettering Cancer Center, where she developed CRISPR and RNAi approaches to study pancreatic cancer in vivo and in organoid models. Dr. Livshits conducted her thesis research in the laboratory of Dr. Elaine Fuchs at The Rockefeller University, where she studied mechanisms of skin development and regeneration. Her doctoral and postdoctoral work has been published in peer-reviewed academic journals including Nature, Nature Medicine, Nature Biotechnology, eLife, PNAS, and Human Gene Therapy. Dr. Livshits received her BS from Brandeis University, her PhD from The Rockefeller University, and was a Postdoctoral Research Fellow at Memorial Sloan Kettering Cancer Center.Follow on LinkedIn Geulah Livshits' Ratings History at Chardan Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsKRYSKrystal Biotech8/22/2025Lower Price Target$145.70$216.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals8/20/2025Reiterated Rating$3.43$11.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics8/15/2025Boost Price Target$46.10$60.00Buy$0.0000.00% ROIMGXMetagenomi8/15/2025Lower Price Target$1.86$11.00Buy$0.0000.00% ROILXEOLexeo Therapeutics8/15/2025Lower Price Target$4.72$15.00Buy$0.0000.00% ROISLDBSolid Biosciences8/14/2025Reiterated Rating$6.10$15.00Buy$0.0000.00% ROIIMRXImmuneering8/14/2025Reiterated Rating$3.04$13.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics8/12/2025Reiterated Rating$5.53$25.00Buy$0.0000.00% ROITSHATaysha Gene Therapies8/12/2025Boost Price Target$2.91$10.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals8/11/2025Lower Price Target$2.86$11.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. NTLAIntellia Therapeutics8/11/2025Lower Price Target$10.79$60.00Buy$0.0000.00% ROIIOVAIovance Biotherapeutics8/8/2025Lower Price Target$2.64$20.00Buy$0.0000.00% ROIPRMEPrime Medicine8/8/2025Lower Price Target$3.79$10.00Buy$0.0000.00% ROISNTISenti Biosciences8/8/2025Reiterated Rating$1.58$12.00Buy$0.0000.00% ROITNYATenaya Therapeutics8/7/2025Reiterated Rating$0.67$9.00Buy$0.0000.00% ROIKRYSKrystal Biotech8/5/2025Reiterated Rating$134.94$219.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics8/5/2025Reiterated Rating$55.59$82.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics8/1/2025Reiterated Rating$4.50$25.00Buy$0.0000.00% ROIKRYSKrystal Biotech7/25/2025Reiterated Rating$150.00$219.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals7/24/2025Lower Price Target$3.21$12.00Buy$0.0000.00% ROIIOVAIovance Biotherapeutics7/23/2025Reiterated Rating$3.13$25.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics7/3/2025Reiterated Rating$4.31$25.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics6/26/2025Reiterated Rating$46.39$82.00Buy$0.0000.00% ROIPASGPassage Bio6/24/2025Reiterated Rating$6.70$120.00Buy$0.0000.00% ROIIMRXImmuneering6/18/2025Reiterated Rating$1.82$13.00Buy$0.0000.00% ROISNTISenti Biosciences6/12/2025Reiterated Rating$2.81$12.00Buy$0.0000.00% ROITSHATaysha Gene Therapies5/29/2025Boost Price Target$2.44$9.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/28/2025Lower Price Target$2.33$17.00Buy$0.0000.00% ROISLDBSolid Biosciences5/19/2025Lower Price Target$2.77$15.00Buy$0.0000.00% ROIPRMEPrime Medicine5/19/2025Lower Price Target$1.29$12.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/16/2025Boost Price Target$6.72$46.00Buy$0.0000.00% ROIIPSCCentury Therapeutics5/16/2025Lower Price Target$0.56$6.00Buy$0.0000.00% ROIMGXMetagenomi5/15/2025Lower Price Target$1.50$12.00Buy$0.0000.00% ROILXEOLexeo Therapeutics5/13/2025Lower Price Target$2.63$20.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/9/2025Reiterated Rating$8.28$68.00Buy$0.0000.00% ROITNYATenaya Therapeutics5/9/2025Reiterated Rating$0.44$9.00Buy$0.0000.00% ROIIOVAIovance Biotherapeutics5/9/2025Lower Price Target$1.76$25.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals5/9/2025Lower Price Target$6.97$45.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics5/9/2025Lower Price Target$3.08$25.00Buy$0.0000.00% ROIKRYSKrystal Biotech5/7/2025Reiterated Rating$139.47$219.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics5/7/2025Lower Price Target$33.21$82.00Buy$0.0000.00% ROIIMRXImmuneering5/6/2025Reiterated Rating$1.25$13.00Buy$0.0000.00% ROISNTISenti Biosciences5/2/2025Reiterated Rating$3.25$12.00Buy$0.0000.00% ROIPVLAPalvella Therapeutics4/9/2025Initiated Coverage$20.51$50.00Buy$0.0000.00% ROILXEOLexeo Therapeutics4/8/2025Lower Price Target$1.79$22.00Buy$0.0000.00% ROILXEOLexeo Therapeutics3/25/2025Reiterated Rating$4.09$25.00Buy$0.0000.00% ROIIPSCCentury Therapeutics3/24/2025Lower Price Target$0.56$7.00Buy$0.0000.00% ROIIMRXImmuneering3/24/2025Reiterated Rating$1.80$13.00Buy$0.0000.00% ROIPRMEPrime Medicine3/20/2025Boost Price Target$2.00$16.00Buy$0.0000.00% ROITNYATenaya Therapeutics3/12/2025Lower Price Target$0.54$9.00Buy$0.0000.00% ROISLDBSolid Biosciences3/7/2025Reiterated Rating$5.42$16.00Buy$0.0000.00% ROIPASGPassage Bio3/4/2025Lower Price Target$8.51$120.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics3/4/2025Lower Price Target$4.14$28.00Buy$0.0000.00% ROIIOVAIovance Biotherapeutics3/3/2025Lower Price Target$4.24$30.00Buy$0.0000.00% ROIPRMEPrime Medicine3/3/2025Reiterated Rating$2.52$15.00Buy$0.0000.00% ROIRCKTRocket Pharmaceuticals2/28/2025Lower Price Target$9.49$54.00Buy$0.0000.00% ROINTLAIntellia Therapeutics2/28/2025Lower Price Target$9.92$68.00Buy$0.0000.00% ROITSHATaysha Gene Therapies2/26/2025Reiterated Rating$1.62$7.00Buy$0.0000.00% ROIKRYSKrystal Biotech2/20/2025Boost Price Target$176.17$218.00Buy$0.0000.00% ROISLDBSolid Biosciences2/19/2025Boost Price Target$5.30$16.00Buy$0.0000.00% ROICRSPCRISPR Therapeutics2/13/2025Lower Price Target$43.30$84.00Buy$0.0000.00% ROIFDMT4D Molecular Therapeutics2/11/2025Lower Price Target$5.32$30.00Buy$0.0000.00% ROICRGXCARGO Therapeutics1/30/2025Downgrade$13.19Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.